You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

UAS7

Showing 1 - 25 of 107
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Spontaneous Urticaria Trial in Worldwide (Tezepelumab Dose 1, Tezepelumab Dose 2, Omalizumab)

Recruiting
  • Chronic Spontaneous Urticaria
  • Tezepelumab Dose 1
  • +3 more
  • Birmingham, Alabama
  • +81 more
Aug 4, 2022

Chronic Spontaneous Urticaria, Chronic Urticaria, Idiopathic Trial in Copenhagen (omalizumab 300 mg every four weeks, omalizumab

Not yet recruiting
  • Chronic Spontaneous Urticaria
  • Chronic Urticaria, Idiopathic
  • omalizumab 300 mg every four weeks
  • omalizumab 300 mg every six weeks
  • Copenhagen, Copenhagen N, Denmark
    Department of Dermatology, Bispebjerg Hospital
Jun 21, 2023

Urticaria, Chronic Spontaneous Urticaria, Chronic Idiopathic Urticaria Trial (Povorcitinib, Placebo)

Not yet recruiting
  • Urticaria
  • +5 more
  • (no location specified)
Jul 6, 2023

Chronic Spontaneous Urticaria Trial (Remibrutinib, Placebo to remibrutinib, Placebo to omalizumab)

Not yet recruiting
  • Chronic Spontaneous Urticaria
  • (no location specified)
Sep 20, 2023

Chronic Spontaneous Urticaria Trial (LOU064 (blinded), )

Not yet recruiting
  • Chronic Spontaneous Urticaria
  • LOU064 (blinded)
  • placebo
  • (no location specified)
Dec 23, 2022

Xolair® in Pediatric Chronic Spontaneous Urticaria in China

Not yet recruiting
  • Chronic Spontaneous Urticaria
  • Xolair
  • (no location specified)
Sep 19, 2023

Chronic Spontaneous Urticaria Trial (Tirabrutinib, Placebo)

Withdrawn
  • Chronic Spontaneous Urticaria
  • (no location specified)
Jul 22, 2021

Chronic Spontaneous Urticaria Trial in Canada, United States (Oral EP262, Placebo)

Recruiting
  • Chronic Spontaneous Urticaria
  • Oral EP262
  • Placebo
  • Birmingham, Alabama
  • +7 more
Oct 5, 2023

Chronic Spontaneous Urticaria Trial in Jacksonville (Nucala)

Recruiting
  • Chronic Spontaneous Urticaria
  • Jacksonville, Florida
    Mayo Clinic in Florida
Nov 30, 2022

Chronic Spontaneous Urticaria (CSU) Trial (LOU064 (blinded), Placebo, LOU064 (open label))

Not yet recruiting
  • Chronic Spontaneous Urticaria (CSU)
  • LOU064 (blinded)
  • +2 more
  • (no location specified)
Aug 22, 2022

Chronic Spontaneous Urticaria Trial in Japan (LOU064)

Recruiting
  • Chronic Spontaneous Urticaria
  • Nagoya, Aichi, Japan
  • +11 more
Jul 14, 2022

Chronic Spontaneous Urticaria Trial in Worldwide (LOU064)

Active, not recruiting
  • Chronic Spontaneous Urticaria
  • Litchfield Park, Arizona
  • +68 more
Jul 19, 2022

Chronic Spontaneous Urticaria Trial in Worldwide (rilzabrutinib, )

Recruiting
  • Chronic Spontaneous Urticaria
  • Caba, Buenos Aires, Argentina
  • +66 more
Jan 20, 2023

Chronic Spontaneous Urticaria Trial in Worldwide (Benralizumab, Placebo and Benralizumab)

Active, not recruiting
  • Chronic Spontaneous Urticaria
  • Benralizumab
  • Placebo and Benralizumab
  • Scottsdale, Arizona
  • +39 more
Jan 16, 2023

Chronic Spontaneous Urticaria Trial in Japan (TAS5315 Dose 1, TAS5315 Dose 2, TAS5315 Dose 3)

Recruiting
  • Chronic Spontaneous Urticaria
  • TAS5315 Dose 1
  • +5 more
  • Fukuoka, Japan
  • +4 more
Aug 15, 2022

Urticaria, Angiœdema Trial in Colombes (Placebo Oral Tablet, Cortancyl Oral Tablet, Levocetirizine Oral Tablet)

Recruiting
  • Urticaria
  • Angiœdema
  • Placebo Oral Tablet
  • +2 more
  • Colombes, Ile De France, France
    Hospital Louis MOURIER
Dec 7, 2022

Chronic Spontaneous Urticaria Trial in Worldwide (Ligelizumab, Omalizumab, Placebo)

Completed
Has Results
  • Chronic Spontaneous Urticaria
  • Ligelizumab
  • +2 more
  • Gilbert, Arizona
  • +160 more
Dec 12, 2022

Chronic Spontaneous Urticaria Trial in Worldwide (Ligelizumab)

Terminated
  • Chronic Spontaneous Urticaria
  • Birmingham, Alabama
  • +254 more
Jan 31, 2023

Chronic Spontaneous Urticaria Trial in Germany, Poland, United States (LY3454738, Placebo)

Terminated
Has Results
  • Chronic Spontaneous Urticaria
  • Bakersfield, California
  • +24 more
Feb 14, 2022

Chronic Spontaneous Urticaria Trial (Cohort 1: TLL018 tablets, Cohort 2: TLL018 tablets, Cohort 3: TLL018 tablets)

Not yet recruiting
  • Chronic Spontaneous Urticaria
  • Cohort 1: TLL018 tablets
  • +2 more
  • (no location specified)
May 10, 2022

Chronic Idiopathic Urticaria Trial (Omalizumab Injection, Xolair Prefilled Syringe)

Not yet recruiting
  • Chronic Idiopathic Urticaria
  • Omalizumab Injection
  • Xolair Prefilled Syringe
  • (no location specified)
Mar 7, 2023

Chronic Spontaneous Urticaria Trial in Hungary, United States (barzolvolimab, Matching Placebo)

Recruiting
  • Chronic Spontaneous Urticaria
  • barzolvolimab
  • Matching Placebo
  • Birmingham, Alabama
  • +44 more
Dec 8, 2022

Chronic Spontaneous Urticaria Trial in Worldwide (Ligelizumab, Omalizumab, Placebo)

Completed
  • Chronic Spontaneous Urticaria
  • Ligelizumab
  • +2 more
  • Birmingham, Alabama
  • +182 more
Aug 5, 2022

China Type II Inflammatory Skin Disease Clinical Research and

Recruiting
  • Atopic Dermatitis Eczema
  • Prurigo Nodularis
    • Beijing, China
      Peking University First Hospital
    Mar 29, 2022

    Urolithiasis Trial in Cairo (Silodosin 8 mg, Placebo)

    Enrolling by invitation
    • Urolithiasis
    • Silodosin 8 mg
    • Placebo
    • Cairo, القاهرة, Egypt
      Ahmed Maher
    Jun 26, 2023